(124) applied anti-SIGLEC15 in TCs and found that it increased anti-tumor immune cells such as the ratio of M1/M2 and infiltration of CD8+ T cells and NK cells in the TME, and decrease the infiltration of pro-tumor immune cells such as M-MDSCs and (PMN)-MDSCs. Here, CD8A is linked to neoplasm.